Michelle Vu, PharmD, MPH

Optum

Poster(s):

• D0382 - Comparison of Surgery Rates in Biologic-Naive Patients With Crohn’s Disease Who Were Treated With Vedolizumab or Ustekinumab: Findings From SOJOURN
  Tuesday, October 25, 2022

  10:00 AM – 12:00 PM ET